< back

Macular telangiectasia type 2

Description

Macular telangiectasia type 2. Macular telangiectasia type 2 (MacTel 2) is a type of acquired macular telangiectasia and is usually bilateral. It is the most common of the three types. Its pathophysiology involves neurodegenerative processes, vascular inflammation and vascular occlusion and ectasia phenomena that lead to degeneration and loss of outer retinal layers that can end up forming lamellar pseudoholes and formation of cystic-looking cavities, telangiectatic vessels in the macular area, hyperplasia of the retinal pigment epithelium (RPE) and migration to internal layers, appearance of crystalline deposits below the internal limiting membrane and development of neovascular membranes in advanced stages.

The following classification has been proposed:

  • Stage 1: Normal fundoscopic examination. Very subtle changes in autofluorescence.
  • Stage 2: Loss of retinal transparency. Hyperautofluorescence. Mild telangiectatic changes without exudation. Sublimiting internal crystalline deposits.
  • Stage 3: Moderate telangiectatic changes. Right-angled venules and capillary remodeling in the outer layers of the retina, without exudation.
  • Stage 4: Pigmentary changes due to hyperplasia and intraretinal migration of RPE cells. Degenerative changes.
  • Stage 5: Reino-choroidal anastomosis with exudation or hemorrhages.

Comments

Indication

75-year-old woman being followed up for macular telangiectasia type 2 in both eyes (AO). Background: Neovascular membranes in AO secondary to MacTel 2 treated with intravitreal injections of anti-angiogenic agents (anti VEGF). Cataract surgery with AO intraocular lens implantation. Corrected vision of 0.4 in the right eye (OD) and 0.8 in the left eye (LE).